Graefes Arch Clin Exp Ophthalmol (2017) 255:1683–1684 DOI 10.1007/s00417-017-3688-8 LETTER TO THE EDITOR (BY INVITATION) Author’s reply: Re: Intracameral cefuroxime in the prevention of postoperative endophthalmitis: an experience from Hong Kong 1 2,3,4 1,2,3,4 Alex Lap-Ki Ng & Patrick Siu-Hung Li & Kenneth Kai-Wang Li Received: 15 April 2017 /Accepted: 24 April 2017 /Published online: 3 May 2017 Springer-Verlag Berlin Heidelberg 2017 Dear Editor, culture-negative case had relatively better visual outcomes. We thank Lim and Tan for their valuable comments on our On the other hand, among our four worse cases with no light article BIntracameral cefuroxime in the prevention of postop- perception, three were caused by Streptococcus species and erative endophthalmitis: an experience from Hong Kong^ . one by Staphylococcus aureus. This is consistent with a re- cently published large series of acute-onset endophthalmitis We agree with them that currently, the optimal choice of antibiotic remains the subject of discussion and debate. Apart after clear corneal cataract surgery, where Yannuzzi et al. re- from cefuroxime, other options such as intracameral ported that visual acuity outcomes were most favorable with moxifloxacin have also been proven to reduce the endophthal- coagulase-negative Staphylococcus (with 51% achieving 20/ mitis rate [2–4]. The
Graefe's Archive for Clinical and Experimental Ophthalmology – Springer Journals
Published: May 3, 2017
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera